These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35084232)

  • 21. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.
    Gültekin MA; Türk HM; Beşiroğlu M; Toprak H; Yurtsever I; Yilmaz TF; Sharifov R; Uysal Ö
    Eur J Radiol; 2020 Apr; 125():108895. PubMed ID: 32109834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
    Li X; Zhang K; Shi Y; Wang F; Meng X
    J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
    Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
    Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases.
    Cui Y; Zhang XP; Sun YS; Tang L; Shen L
    Radiology; 2008 Sep; 248(3):894-900. PubMed ID: 18710982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy.
    Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI
    Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients.
    Koh DM; Scurr E; Collins D; Kanber B; Norman A; Leach MO; Husband JE
    AJR Am J Roentgenol; 2007 Apr; 188(4):1001-8. PubMed ID: 17377036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of ADC measurements in predicting overall survival in patients undergoing
    Alis D; Durmaz ESM; Gulsen F; Bas A; Kabasakal L; Sager S; Numan F
    Clin Imaging; 2019; 57():124-130. PubMed ID: 31220677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
    Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
    Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study.
    Littooij AS; Humphries PD; Olsen ØE
    Pediatr Radiol; 2015 Oct; 45(11):1651-60. PubMed ID: 25951925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases.
    Mungai F; Pasquinelli F; Mazzoni LN; Virgili G; Ragozzino A; Quaia E; Morana G; Giovagnoni A; Grazioli L; Colagrande S
    Radiol Med; 2014 Aug; 119(8):625-33. PubMed ID: 24408046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of therapeutic response to hepatic arterial infusion chemotherapy of liver metastases from colorectal cancer using diffusion-weighted MR imaging.
    Marugami N; Tanaka T; Kitano S; Hirohashi S; Nishiofuku H; Takahashi A; Sakaguchi H; Matsuoka M; Otsuji T; Takahama J; Higashiura W; Kichikawa K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):638-46. PubMed ID: 19238482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and
    Uutela A; Ovissi A; Hakkarainen A; Ristimäki A; Lundbom N; Kallio R; Soveri LM; Salminen T; Ålgars A; Halonen P; Ristamäki R; Nordin A; Blanco Sequeiros R; Rinta-Kiikka I; Lantto E; Virtanen J; Pääkkö E; Liukkonen E; Saunavaara J; Ryymin P; Lammentausta E; Osterlund P; Isoniemi H;
    ESMO Open; 2021 Aug; 6(4):100208. PubMed ID: 34325107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Therapeutic Effect to Treatment in Patients with Colorectal Liver Metastases Using Functional Magnetic Resonance Imaging and RECIST Criteria: A Pilot Study in Comparison between Bevacizumab-Containing Chemotherapy and Standard Chemotherapy.
    Zhu HB; Xu D; Zhang XY; Li XT; Xing BC; Sun YS
    Ann Surg Oncol; 2022 Jun; 29(6):3938-3949. PubMed ID: 35013857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.
    Fouladi DF; Zarghampour M; Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Khoshpouri P; Kamel IR
    Eur Radiol; 2020 Jan; 30(1):291-300. PubMed ID: 31209620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of diffusion-weighted magnetic resonance imaging in evaluation of early therapeutic response after CT-guided microwave ablation of inoperable lung neoplasms.
    Vogl TJ; Emara EH; Elhawash E; Naguib NNN; Aboelezz MO; Abdelrahman HM; Saber S; Nour-Eldin NA
    Eur Radiol; 2022 May; 32(5):3288-3296. PubMed ID: 34797384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
    Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
    Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.